Informed Consent: When, Why, and How It’s Obtained
Aside from being a regulatory and ethical requirement, informed consent is a good way to ensure participant knowledge and develop a foundation trust between researcher and participant.
Helping to Ensure the Success of a Phase III Vaccine Trial
Understanding the Complexity and Uniqueness of Phase I Trials
There are many distinctions that set Phase I trials apart from the rest. For sites aiming for a successful Phase I trial, working with an organization that understands the nuances is key.
A Guide to System Integrations and Single Sign-On for Clinical Operations Teams
The growing complexity of clinical trials is being met with a new generation of eClinical tools – electronic data capture, centralized trial platforms, and risk-based management tools.
How to Improve Your Site Compliance
Many clinical trial sites face challenges to stay compliant on a study. It is important for sites to adhere to the myriad of requirements that constitute Good Clinical Practices (GCP).
Meeting Multiple Challenges for a Uniquely Challenging Trial
Demonstrating the Impact of the Longboat Portal on Recruitment Success
The Many Faces of “Coercion” and “Undue Influence”
Coercion and undue influence in research can be complicated. Understand what these terms mean and how to appropriately protect against them.
Takeaways From the FDA’s VRBPAC Meeting – October 22, 2020
On October 22, 2020, the FDA's VRBPAC met to discuss the development, authorization, and licensure of vaccines to prevent COVID-19.
Beginner’s Guide to Investigator-Initiated Trials
In investigator-initiated trials, an investigator takes on the clinical study as both the sponsor and investigator. Learn more about IITs impact on the clinical research industry.
Is GDPR Coming to the US? CCPA and Its Impact on Research
New California regulations apply to companies who have information about CA residents regardless of where the company is located. Read more: